Altaris sets $800 mln target, $1 bln hard cap for Fund IV

16 May 2017•2 mins read
healthcare, private equity, merger M&A, Thompson Street Capital Partners, Firma Clinical Research
LinkedInXEmail
LinkedInXEmail